Chugai Pharm Unsp/Adr (CHGCY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 09-2024 | 03-2024 | |
| Sales | 0 | 0 | 1,903,829 | 0 | 1,587,558 |
| Cost of Goods | N/A | N/A | 579,632 | N/A | 488,765 |
| Gross Profit | N/A | N/A | 1,324,198 | N/A | 1,098,793 |
| Operating Expenses | 0 | 0 | 422,939 | 0 | 430,409 |
| Operating Income | N/A | N/A | 901,897 | N/A | 669,156 |
| Interest Expense | 0 | 0 | -20 | 0 | -20 |
| Other Income | 0 | 0 | -5,445 | 0 | 80 |
| Pre-tax Income | 0 | 0 | 896,471 | 0 | 669,256 |
| Income Tax | N/A | N/A | 254,727 | N/A | 170,770 |
| Net Income Continuous | N/A | N/A | 641,744 | N/A | 498,487 |
| Net Income | $N/A | $N/A | $641,744 | $N/A | $498,487 |
| EPS Basic Total Ops | N/A | N/A | 0.20 | N/A | 0.15 |
| EPS Basic Continuous Ops | N/A | N/A | 0.20 | N/A | 0.15 |
| EPS Diluted Total Ops | N/A | N/A | 0.20 | N/A | 0.15 |
| EPS Diluted Continuous Ops | N/A | N/A | 0.20 | N/A | 0.15 |
| EPS Diluted Before Non-Recurring Items | 0.23 | 0.20 | 0.19 | 0.22 | 0.15 |
| EBITDA(a) | $N/A | $N/A | $901,890 | $N/A | $669,149 |